{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:41:10Z","timestamp":1778910070331,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Research and Development Plan of China","award":["2016YFC1200904"],"award-info":[{"award-number":["2016YFC1200904"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2017.07.101","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T09:15:22Z","timestamp":1502183722000},"page":"5172-5178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions"],"prefix":"10.1016","volume":"35","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.07.101_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.NURSE.0000482873.70955.7b","article-title":"Lassa fever","volume":"46","author":"Coyle","year":"2016","journal-title":"Nursing"},{"key":"10.1016\/j.vaccine.2017.07.101_b0010","first-page":"600","article-title":"Viral evolution: the history of Lassa virus","volume":"13","author":"Attar","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3855\/jidc.8148","article-title":"As Ebola winds down, Lassa fever reemerges yet again in West Africa","volume":"10","author":"Makinde","year":"2016","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2017.07.101_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00938-16","article-title":"Genome sequence of lassa virus isolated from the first domestically acquired case in Germany","volume":"4","author":"Wolff","year":"2016","journal-title":"Genome Announc"},{"key":"10.1016\/j.vaccine.2017.07.101_b0025","doi-asserted-by":"crossref","first-page":"ofw198","DOI":"10.1093\/ofid\/ofw198","article-title":"Imported case of Lassa fever in Sweden with encephalopathy and sensorineural hearing deficit","volume":"3","author":"Grahn","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.101_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.07.101_b0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.329","article-title":"Towards a human Lassa fever vaccine","volume":"11","author":"Fisher-Hoch","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0040","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0045","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0050","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.101_b0055","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"Jiang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.101_b0060","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.07.101_b0065","doi-asserted-by":"crossref","first-page":"e0003736","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.07.101_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2011.10.011","article-title":"Identification of an antioxidant small-molecule with broad-spectrum antiviral activity","volume":"93","author":"Panchal","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.07.101_b0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.07.101_b0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2014.10.001","article-title":"Animal models of viral hemorrhagic fever","volume":"112","author":"Smith","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.07.101_b0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","article-title":"Evaluation of Lassa antiviral compound ST-193 in a guinea pig model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.07.101_b0090","unstructured":"World Health Organization. WHO publishes list of top emerging diseases most likely to cause major epidemics; 2015. http:\/\/www.who.int\/medicines\/ebolatreatment\/WHO-list-of-top-emerging-diseases\/en\/."},{"key":"10.1016\/j.vaccine.2017.07.101_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/erv.12.139","article-title":"The search for animal models for Lassa fever vaccine development","volume":"12","author":"Lukashevich","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.07.101_b0100","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.101_b0105","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","article-title":"Characterization of the interaction of Lassa fever virus with its cellular receptor alpha-dystroglycan","volume":"79","author":"Kunz","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0110","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.101_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.vaccine.2017.07.101_b0120","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1038\/srep42769","article-title":"Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system","volume":"7","author":"Nie","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.07.101_b0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0000000000000595","article-title":"HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection","volume":"29","author":"Liu","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2017.07.101_b0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1440-1681.12654","article-title":"Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant","volume":"44","author":"Ruan","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0135","doi-asserted-by":"crossref","first-page":"e33392","DOI":"10.1371\/journal.pone.0033392","article-title":"A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.07.101_b0140","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00705-014-2079-2","article-title":"Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro","volume":"159","author":"Zhu","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0145","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/JVI.00274-06","article-title":"Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection","volume":"80","author":"Shrestha","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0150","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.4049\/jimmunol.181.10.7356","article-title":"Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+CD25+regulatory T cells","volume":"181","author":"Yu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0155","first-page":"409","article-title":"Morphology and morphogenesis of arenaviruses","volume":"52","author":"Murphy","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.07.101_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-4-1","article-title":"Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus","volume":"4","author":"Uckun","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.101_b0165","doi-asserted-by":"crossref","first-page":"e72290","DOI":"10.1371\/journal.pone.0072290","article-title":"Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers","volume":"8","author":"Rieger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.07.101_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.07.101_b0175","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.101_b0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/vaccines1030262","article-title":"Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation","volume":"1","author":"Cashman","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2017.07.101_b0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virusres.2011.09.005","article-title":"Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses","volume":"162","author":"Grant-Klein","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.07.101_b0190","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14760584.2016.1184575","article-title":"Vaccine platforms to control Lassa fever","volume":"15","author":"Lukashevich","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.07.101_b0195","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/v4112766","article-title":"Immune responses and Lassa virus infection","volume":"4","author":"Russier","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.07.101_b0200","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical sequencing uncovers origins and evolution of Lassa virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:57:17Z","timestamp":1535565437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1731037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X1731037X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}